Goldman Sachs Group Inc Eq Rx, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$1.66 - $2.31 $2.22 Million - $3.09 Million	1,336,239 New	1,336,239 $2.97 Million
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $263,629 - $366,858	158,813 Added 13.49%	1,336,239 $2.97 Million
Q2 2023 May 14, 2024	SELL	$1.61 - $1.96 $1.21 Million - $1.47 Million	-750,386 Reduced 38.92%	1,177,426 $2.19 Million
Q2 2023 Aug 14, 2023	SELL	$1.61 - $1.96 $1.21 Million - $1.47 Million	-750,386 Reduced 38.92%	1,177,426 $2.19 Million
Q1 2023 May 14, 2024	BUY	$1.8 - $2.83 $569,860 - $895,946	316,589 Added 19.65%	1,927,812 $3.74 Million
Q1 2023 May 11, 2023	BUY	$1.8 - $2.83 $569,860 - $895,946	316,589 Added 19.65%	1,927,812 $3.74 Million
Q4 2022 May 14, 2024	SELL	$2.05 - $5.5 $1.61 Million - $4.31 Million	-783,975 Reduced 32.73%	1,611,223 $3.96 Million
Q4 2022 Feb 13, 2023	SELL	$2.05 - $5.5 $1.61 Million - $4.31 Million	-783,975 Reduced 32.73%	1,611,223 $3.96 Million
Q3 2022 May 14, 2024	BUY	$0.94 - $5.99 $505,969 - $3.22 Million	538,265 Added 28.99%	2,395,198 $11.9 Million
Q3 2022 Nov 10, 2022	BUY	$0.94 - $5.99 $505,969 - $3.22 Million	538,265 Added 28.99%	2,395,198 $11.9 Million
Q2 2022 May 14, 2024	BUY	$3.2 - $5.69 $5.94 Million - $10.6 Million	1,856,933 New	1,856,933 $8.71 Million
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $2.19 Million - $3.9 Million	685,598 Added 58.53%	1,856,933 $8.71 Million
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $3.08 Million - $8.13 Million	1,100,670 Added 1557.59%	1,171,335 $4.84 Million
Q4 2021 Feb 14, 2022	BUY	$5.92 - $9.98 $418,336 - $705,236	70,665 New	70,665 $482,000

Others Institutions Holding EQRX

# of Institutions

Shares Held

67.8M

Call Options Held

Put Options Held

Ah Equity Partners Bio Iii, L.L.C. Menlo Park, CA

19.2M
Shares

$0
100.0% of portfolio
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA

17.4M
Shares

$0
60.15% of portfolio
Arboretum Ventures, Inc.

13.9M
Shares

$0
63.96% of portfolio
Ah Equity Partners Lsv I, L.L.C. Menlo Park, CA

11.4M
Shares

$0
8.42% of portfolio
Ah Equity Partners Lsv Ii, L.L.C. Menlo Park, CA

5M
Shares

$0
11.61% of portfolio

View Full List

About EQRx, Inc.

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

More about EQRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account